Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
146.80    0.60 (0.41%)
Bid:
144.20
Ask:
147.00
Spread: 2.80 (1.942%)
Market Cap: £250.83m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Pre Close Trading Statement

24 Jun 2009 07:00

RNS Number : 3872U
McBride PLC
24 June 2009
 



McBride plc

24 June 2009

Pre Close Trading Statement

McBride plc, Europe's leading provider of private label household and personal care products, today provides an update on trading for the year ended 30 June 2009 prior to entering its closed period.

Group revenues in the fourth quarter (to 30 June) are stronger than the previous quarter reflecting continuing strong growth in France and Italy, and an improvement in UK sales including some contract gains. Year on year revenue growth on a constant currency basis is expected to be 6% for the fourth quarter.

Full year revenue growth, on a constant currency basis, is expected to be 4%, benefiting from Private Label gaining market share in our major markets. 

The Board expects to report operating profits for the year ended 30 June 2009, before amortisation of intangible assets and exceptional items, of not less than £35m.

Year-end net debt is expected to be less than £90m, subject to exchange rate movements, reflecting continuing strong operational flows. As a result of this finance costs are slightly lower than expected.

Miles Roberts, Chief Executive, said "we are pleased to have ended the year strongly as demand for our Private Label offering continues to grow. Our continuing focus on driving operational efficiencies has been reflected in a satisfactory second half and full year operating performance."

The Group intends to announce its preliminary results for the year ended 30 June 2009 on 3 September 2009.

 

For further information please contact

McBride plc

Miles Roberts, Chief Executive

020 7539 7852

Paul Bergin, Interim Finance Director

020 7539 7860

Financial Dynamics

Andrew Dowler

020 7831 3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPUUCGQUPBGQW
Date   Source Headline
20th Nov 20254:40 pmRNSAGM Statement
20th Nov 20257:00 amRNSAGM Trading Update and Share Buyback
18th Nov 20259:42 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSTotal Voting Rights
27th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20256:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20257:00 amRNSApplication for Additional Listing of Shares
17th Oct 20256:23 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSAnnual Financial Report
24th Sep 20257:00 amRNSRedemption of B Shares
19th Sep 20257:00 amRNSDirector/PDMR Shareholding
18th Sep 20259:04 amRNSEx-dividend date - Correction
17th Sep 20257:00 amRNSFinal Results
5th Sep 20257:00 amRNS-RInvestor Webinar on 18 September 2025
16th Jul 20257:00 amRNSFull Year Trading Update
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSHolding(s) in Company
29th May 20253:19 pmRNSHolding(s) in Company
23rd May 20251:42 pmRNSHolding(s) in Company
19th May 20257:00 amRNSHolding(s) in Company
12th May 20257:00 amRNSHolding(s) in Company
6th May 20257:00 amRNSHolding(s) in Company
29th Apr 20257:00 amRNSHolding(s) in Company
22nd Apr 20257:00 amRNSHolding(s) in Company
8th Apr 20257:00 amRNSHolding(s) in Company
28th Feb 20255:00 pmRNSHolding(s) in Company
25th Feb 20257:00 amRNSHalf-year Report
18th Feb 20256:15 pmRNSHolding(s) in Company
11th Feb 20254:40 pmRNSHolding(s) in Company
17th Jan 20257:00 amRNSTrading Statement
29th Nov 20247:00 amRNSSuccessful Completion of Refinancing
18th Nov 20241:10 pmRNSDirector/PDMR Shareholding
18th Nov 20241:09 pmRNSDirector/PDMR Shareholding
15th Nov 20241:10 pmRNSDirector/PDMR Shareholding
12th Nov 20246:36 pmRNSResult of Annual General Meeting
12th Nov 20247:00 amRNSAGM Trading Update
6th Nov 20243:53 pmRNSDirector/PDMR Shareholding
31st Oct 20247:00 amRNSDirector/PDMR Shareholding
25th Oct 20243:48 pmRNSDirector/PDMR Shareholding
8th Oct 20246:25 pmRNSDirector/PDMR Shareholding
7th Oct 20247:00 amRNSAnnual Financial Report
1st Oct 20245:30 pmRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSDirector/PDMR Shareholding
24th Sep 20243:38 pmRNSDirector/PDMR Shareholding
20th Sep 20245:17 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSDirector/PDMR Shareholding
17th Sep 20247:00 amRNSFinal Results
16th Jul 20247:00 amRNSFull Year Trading Update
3rd Jul 20242:33 pmRNSHolding(s) in Company
14th Jun 20247:00 amRNSGrant and vesting of RSU Awards to PDMR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.